Andere talen NVN Liquidation, Inc.

Aandelen

Beurs gesloten - OTC Markets Andere beurzen 21:32:31 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,000001 ^USD	-99,88%		-.--%	-99,80%

2023	Openbaarmakingsverklaring en liquidatieplan op tussentijdse basis goedgekeurd voor NVN Liquidation, Inc.	CI
2023	Eerste motie voor verlenging exclusiviteitsperiode goedgekeurd voor NVN Liquidation, Inc.	CI

First Amended Combined Liquidation Plan and Disclosure Statement Filed by NVN Liquidation, Inc.	17/01
Modified Disclosure Statement Approved on Interim Basis for NVN Liquidation, Inc.	19/12
First Motion for Exclusivity Period Extension Approved For NVN Liquidation, Inc.	01/12
Combined Liquidation Plan and Disclosure Statement Filed by NVN Liquidation, Inc.	22/11
First Motion for Exclusivity Period Extension Filed by NVN Liquidation, Inc.	13/11
Novan, Inc. has Changed its Name to NVN Liquidation, Inc	20-10-23
Novan, Inc. Announces the Resignation of John M. Gay as Chief Financial Officer	27-09-23
Novan, Inc. Announces the Resignation of John M. Gay as Secretary	27-09-23
Ligand Pharmaceuticals Incorporated completed the acquisition of Substantially All of the Assets of Novan, Inc. for $12.2 million.	27-09-23
Motion for Asset Sale Approved for Novan, Inc.	12-09-23
Motion for Asset Sale Approved for Novan, Inc.	12-09-23
Notice of selection of Successful Bidder Filed by Novan, Inc.	01-09-23
Notice of selection of Successful Bidder Filed by Novan, Inc.	31-08-23
Final DIP Financing Approved for Novan, Inc.	21-08-23
Bidding Procedure Approved for Novan, Inc.	15-08-23
Novan, Inc.(OTCPK:NOVN.Q) dropped from NASDAQ Composite Index	25-07-23
Interim DIP Financing Approved for Novan, Inc.	21-07-23
Novan, Inc.(NasdaqCM:NOVN) dropped from S&P TMI Index	20-07-23
Motion for Joint Administration Approved for Novan, Inc.	19-07-23
Sector Update: Health Care Stocks Slipping Late Monday	17-07-23

Geen resultaten voor deze zoekopdracht